
==== Front
Amino Acids
Amino Acids
Amino Acids
0939-4451 1438-2199 Springer-Verlag Vienna 

18235997
611
10.1007/s00726-007-0611-3
Article
Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin
Guo X.-L. 1 Li L. 1 Wei D.-Q. dqwei@sjtu.edu.cn 12 Zhu Y.-S. 1 Chou K.-C. 2  grid.16821.3c0000000403688293College of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, China 
 Gordon Life Science Institute, San Diego, California U.S.A. 
31 1 2008 
2008 
35 2 375 382
29 8 2007 23 9 2007 © Springer-Verlag 2008This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Summary.
The cleavage property of hemagglutinin (HA) by different proteases was the prime determinant for influenza A virus pathogenicity. In order to understand the cleavage mechanism, molecular modeling tools were utilized to study the coupled model systems of the proteases, i.e., trypsin and furin and peptides of the cleavage sites specific to H5N1 and H1 HAs, which constitute models of HA precursor in complex with cleavage proteases. The peptide segments ‘RERRRKKR ↓ G’ and ‘SIQSR ↓ G’ from the high pathogenic H5N1 H5 and the low pathogenic H1N1 H1 cleavage sites were docking to the trypsin and furin active pockets, respectively. It was observed through the docking studies that trypsin was able to recognize and cleave both the high pathogenic and low pathogenic hemagglutinin, while furin could only cleave the high pathogenic hemagglutinin. An analysis of binding energies indicated that furin got most of its selectivity due to the interactions with P1, P4, and P6, while having less interaction with P2 and little interactions with P3, P5, P7, and P8. Some mutations of H5N1 H5 cleavage sequence fitted less well into furin and would reduce high pathogenicity of the virus. These findings hint that we should focus at the subsites P1, P4, and P6 for developing drugs against H5N1 viruses.

Keywords: Trypsin – Furin – H5N1 hemagglutinin – Cleavage mechanism – Pathogenicityissue-copyright-statement© Springer-Verlag 2008
==== Body
Authors’ address: Dong-Qing Wei, College of Life Science and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China
==== Refs
References
Buck M Bouguet-Bonnet S Pastor RW MacKerell AD Jr Importance of the CMAP correction to the CHARMM22 protein force field: dynamics of hen lysozyme
Biophys J 2006 90 L36 L38
10.1529/biophysj.105.078154 16361340 
Chou KC  A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins
J Biol Chem 1993 268 16938 16948
8349584 
Chou KC  Review: prediction of HIV protease cleavage sites in proteins
Anal Biochem 1996 233 1 14
10.1006/abio.1996.0001 8789141 
Chou KC  Insights from modelling the 3D structure of the extracellular domain of alpha7 nicotinic acetylcholine receptor
Biochem Biophys Res Commun 2004a 319 433 438
10.1016/j.bbrc.2004.05.016 15178425 
Chou KC  Molecular therapeutic target for type-2 diabetes
J Proteome Res 2004b 3 1284 1288
10.1021/pr049849v 15595739 
Chou KC  Review: structural bioinformatics and its impact to biomedical science
Curr Med Chem 2004c 11 2105 2134
15279552 
Chou KC  Coupling interaction between thromboxane A2 receptor and alpha-13 subunit of guanine nucleotide-binding protein
J Proteome Res 2005a 4 1681 1686
10.1021/pr050145a 16212421 
Chou KC  Modeling the tertiary structure of human cathepsin-E
Biochem Biophys Res Commun 2005b 331 56 60
10.1016/j.bbrc.2005.03.123 15845357 
Chou KC Carlacci L  Simulated annealing approach to the study of protein structures
Protein Eng 1991 4 661 667
10.1093/protein/4.6.661 1946323 
Chou KC Wei DQ Du QS Sirois S Zhong WZ  Review: progress in computational approach to drug development against SARS
Curr Med Chem 2006 13 3263 3270
10.2174/092986706778773077 17168850 
Chou KC Wei DQ Zhong WZ  Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
Biochem Biophys Res Commun 2003 308 148 151
10.1016/S0006-291X(03)01342-1 12890493 
Du QS Sun H Chou KC  Inhibitor design for SARS coronavirus main protease based on “distorted key theory”
Med Chem 2007a 3 1 6
10.2174/157340607779317616 17266617 
Du QS Wang S Wei DQ Sirois S Chou KC  Molecular modelling and chemical modification for finding peptide inhibitor against SARS CoV Mpro
Anal Biochem 2005 337 262 270
10.1016/j.ab.2004.10.003 15691506 
Du QS Wang SQ Chou KC  Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus
Biochem Biophys Res Commun 2007b 362 525 531
10.1016/j.bbrc.2007.08.025 17707775 
Du QS Wang SQ Wei DQ Zhu Y Guo H Sirois S Chou KC  Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of octapeptide
Peptides 2004 25 1857 1864
10.1016/j.peptides.2004.06.018 15501516 
Hatta M Gao P Halfmann P Kawaoka Y  Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
Science 2001 293 1840 1842
10.1126/science.1062882 11546875 
Henrich S Cameron A Bourenkov GP Kiefersauer R Huber R Lindberg I Bode W Than ME  The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
Nat Struct Biol 2003 10 520 526
10.1038/nsb941 12794637 
Henrich S Lindberg I Bode W Than ME  Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity
J Mol Biol 2005 345 211 227
10.1016/j.jmb.2004.10.050 15571716 
Holyoak T Kettner CA Petsko GA Fuller RS Ringe D  Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases
Biochemistry 2004 43 2412 2421
10.1021/bi035849h 14992578 
Ibrahim BS Shamaladevi N Pattabhi V  Trypsin activity reduced by an autocatalytically produced nonapeptide
J Biomol Struct Dyn 2004 21 737 744
15106996 
Kawaoka Y Webster RG  Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells
Proc Natl Acad Sci USA 1988 85 324 328
10.1073/pnas.85.2.324 2829180 
Kido H Sakai K Kishino Y Tashiro M  Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus
FEBS Lett 1993 322 115 119
10.1016/0014-5793(93)81549-F 8387030 
Krysan DJ Rockwell NC Fuller RS  Quantitative characterization of furin specificity. Energetics of substrate discrimination using an internally consistent set of hexapeptidyl methylcoumarinamides
J Biol Chem 1999 274 23229 23234
10.1074/jbc.274.33.23229 10438496 
Ma W Tang C Lai L  Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant
Biophys J 2005 89 1183 1193
10.1529/biophysj.104.057158 15923233 
Martin J Wharton SA Lin YP Takemoto DK Skehel JJ Wiley DC Steinhauer DA  Studies of the binding properties of influenza hemagglutinin receptor-site mutants
Virology 1998 241 101 111
10.1006/viro.1997.8958 9454721 
Morris GM Goodsell DS Huey R Olson AJ  Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4
J Comput Aided Mol Des 1996 10 293 304
10.1007/BF00124499 8877701 
Radisky ES Lee JM Lu CJ Koshland DE Jr Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates
Proc Natl Acad Sci USA 2006 103 6835 6840
10.1073/pnas.0601910103 16636277 
Rozan L Krysan DJ Rockwell NC Fuller RS  Plasticity of extended subsites facilitates divergent substrate recognition by Kex2 and furin
J Biol Chem 2004 279 35656 35663
10.1074/jbc.M405362200 15159396 
Schechter I Berger A  On the size of the active site in protease. I. Papain
Biochem Biophys Res Commun 1967 27 157 162
10.1016/S0006-291X(67)80055-X 6035483 
Schmidt A Jelsch C Ostergaard P Rypniewski W Lamzin VS  Trypsin revisited: crystallography AT (SUB) atomic resolution and quantum chemistry revealing details of catalysis
J Biol Chem 2003 278 43357 43362
10.1074/jbc.M306944200 12937176 
Sirois S Wei DQ Du QS Chou KC  Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points
J Chem Inf Comput Sci 2004 44 1111 1122
10.1021/ci034270n 15154780 
Steinhauer DA  Role of hemagglutinin cleavage for the pathogenicity of influenza virus
Virology 1999 258 1 20
10.1006/viro.1999.9716 10329563 
Stevens J Blixt O Tumpey TM Taubenberger JK Paulson JC Wilson IA  Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus
Science 2006 312 404 410
10.1126/science.1124513 16543414 
Wang JF Wei DQ Li L Zheng SY Li YX Chou KC  3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design
Biochem Biophys Res Commun 2007a 355 513 519
10.1016/j.bbrc.2007.01.185 17307149 
Wang SQ Du QS Chou KC  Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases
Biochem Biophys Res Commun 2007b 354 634 640
10.1016/j.bbrc.2006.12.235 17266937 
Wang SQ Du QS Zhao K Li AX Wei DQ Chou KC  Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy
Amino Acids 2007c 33 129 135
10.1007/s00726-006-0403-1 16998715 
Wei DQ Du QS Sun H Chou KC  Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands
Biochem Biophys Res Commun 2006a 344 1048 1055
10.1016/j.bbrc.2006.03.210 16647045 
Wei DQ Sirois S Du QS Arias HR Chou KC  Theoretical studies of Alzheimer’s disease drug candidate [(2,4-dimethoxy) benzylidene]-anabaseine dihydrochloride (GTS-21) and its derivatives
Biochem Biophys Res Commun 2005 338 1059 1064
10.1016/j.bbrc.2005.10.047 16256952 
Wei DQ Zhang R Du QS Gao WN Li Y Gao H Wang SQ Zhang X Li AX Sirois S Chou KC  Anti-SARS drug screening by molecular docking
Amino Acids 2006b 31 73 80
10.1007/s00726-006-0361-7 16715412 
Wei H Zhang R Wang C Zheng H Chou KC Wei DQ  Molecular insights of SAH enzyme catalysis and their implication for inhibitor design
J Theor Biol 2007 244 692 702
10.1016/j.jtbi.2006.09.011 17069857 
Wheatley JL Holyoak T  Differential P1 arginine and lysine recognition in the prototypical proprotein convertase Kex2
Proc Natl Acad Sci USA 2007 104 6626 6631
10.1073/pnas.0701983104 17426142 
Wiley DC Skehel JJ  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus
Annu Rev Biochem 1987 56 365 394
10.1146/annurev.bi.56.070187.002053 3304138 
Zhang R Wei DQ Du QS Chou KC  Molecular modeling studies of peptide drug candidates against SARS
Med Chem 2006 2 309 314
10.2174/157340606776930736 16948478

